Clinical trial
Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection
NCT02541786 is registered in ClinicalTrials.gov with Kaohsiung Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection
- Lead sponsor
- Kaohsiung Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- August 31, 2015
- Enrollment
- 177 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori infection